Hemab Therapeutics Holdings, Inc. Common Stock carries a market capitalization of 2.07B, placing it among publicly traded companies globally.
| Market Cap | 2.07B |
| Enterprise Value | N/A |
Hemab Therapeutics Holdings, Inc. Common Stock's stock has gained approximately 30.61765% over the past 52 weeks. The 50-day moving average sits at 44.92, while the 200-day moving average is 37.29.
| Beta (5Y) | N/A |
| 52-Week Price Change | 30.61765% |
| 50-Day Moving Average | 44.92 |
| 200-Day Moving Average | 37.29 |
| Average Volume (20 Days) | N/A |